NCT05254795Active, not recruiting
Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care
Source: ClinicalTrials.gov · Last updated 6 Mar 2026
Brief summary (registry, in English)
This trial will compare Molecular Tumor Board (MTB) assisted care to usual care for patients who have newly diagnosed histologically or cytologically confirmed stage IIb-IV Non-Small Cell Lung Cancer (NSCLC) and are planning to undergo treatment for their cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 659 (actual)
- First submitted
- 14 Feb 2022
- Start date
- 13 Apr 2022
- Primary completion date
- 22 Dec 2026
- Lead sponsor
- Timothy Mullett
- Diseases
- Lung cancer
- NCT number
- NCT05254795
What you commit to
- Study type: Interventional
- Participants enrolled: 659
- From 13 Apr 2022 to the primary completion date, 22 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with targeted therapy, in the opinion of the treating physician.
Other
- Pregnancy
Who the study is looking for
- Clinically suspected or histologically confirmed stage IIb-IV NSCLC who are planning to undergo treatment
- No prior systemic therapies for NSCLC, with the exception of adjuvant therapy for early stage NSCLC. Prior surgery and/or radiation is allowed.
- Ability to understand and the willingness to sign a written informed consent document.
Age in the registry: 18 years to 120 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Kentucky Coordinator of this site? Confirm its status | Lexington | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.